Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Multiple in vitro and in vivo regulatory effects of budesonide in CD4+ T lymphocyte subpopulations of allergic asthmatics.

Pace E, Di Sano C, La Grutta S, Ferraro M, Albeggiani G, Liotta G, Di Vincenzo S, Uasuf CG, Bousquet J, Gjomarkaj M.

PLoS One. 2012;7(12):e48816. doi: 10.1371/journal.pone.0048816. Epub 2012 Dec 12.

2.

Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics.

Pace E, Di Sano C, Ferraro M, Bruno A, Caputo V, Gallina S, Gjomarkaj M.

Pulm Pharmacol Ther. 2015 Jun;32:93-100. doi: 10.1016/j.pupt.2015.02.003. Epub 2015 Feb 24.

PMID:
25722071
3.

Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4.

Botturi K, Lacoeuille Y, Cavaillès A, Vervloet D, Magnan A.

Respir Res. 2011 Feb 28;12:25. doi: 10.1186/1465-9921-12-25.

4.

[Influence of anti-ICOS antibody on quantity and function of CD4(+);CD25(+);Foxp3(+);Treg from lymph and blood of rats with bronchial asthma].

Zhao L, Feng XB, Wang YS, Cui QQ, Cao YY.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Oct;28(10):1029-32. Chinese.

PMID:
23046932
5.

Flt3-L increases CD4+CD25+Foxp3+ICOS+ cells in the lungs of cockroach-sensitized and -challenged mice.

McGee HS, Edwan JH, Agrawal DK.

Am J Respir Cell Mol Biol. 2010 Mar;42(3):331-40. doi: 10.1165/rcmb.2008-0397OC. Epub 2009 May 15.

6.

Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach.

Albano GD, Di Sano C, Bonanno A, Riccobono L, Gagliardo R, Chanez P, Gjomarkaj M, Montalbano AM, Anzalone G, La Grutta S, Ricciardolo FL, Profita M.

PLoS One. 2013;8(4):e58892. doi: 10.1371/journal.pone.0058892. Epub 2013 Apr 3.

7.

Frequency of Foxp3+CD4CD25+ T cells is associated with the phenotypes of allergic asthma.

Matsumoto K, Inoue H, Fukuyama S, Kan-O K, Eguchi-Tsuda M, Matsumoto T, Moriwaki A, Nakano T, Nakanishi Y.

Respirology. 2009 Mar;14(2):187-94. doi: 10.1111/j.1440-1843.2008.01472.x. Epub 2009 Jan 23.

PMID:
19192224
8.

Decreased FOXP3 protein expression in patients with asthma.

Provoost S, Maes T, van Durme YM, Gevaert P, Bachert C, Schmidt-Weber CB, Brusselle GG, Joos GF, Tournoy KG.

Allergy. 2009 Oct;64(10):1539-46. doi: 10.1111/j.1398-9995.2009.02056.x. Epub 2009 Apr 9.

9.

Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.

Terzieva V, Popova D, Kicheva M, Todorova Y, Markova R, Martinova F, Elenkov I, Yankova M.

Int Immunopharmacol. 2009 Jul;9(7-8):831-6. doi: 10.1016/j.intimp.2009.03.009. Epub 2009 Mar 18.

PMID:
19303058
10.

Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.

Wang LH, Lin YH, Yang J, Guo W.

Int Arch Allergy Immunol. 2009;148(3):199-210. doi: 10.1159/000161580. Epub 2008 Oct 10.

PMID:
18849611
11.

Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics.

Kawayama T, Kinoshita T, Imaoka H, Gauvreau GM, O'Byrne PM, Aizawa H.

Respirology. 2008 Nov;13(7):1000-1007. doi: 10.1111/j.1440-1843.2008.01381.x.

PMID:
18699801
12.

Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.

Scholzen A, Mittag D, Rogerson SJ, Cooke BM, Plebanski M.

PLoS Pathog. 2009 Aug;5(8):e1000543. doi: 10.1371/journal.ppat.1000543. Epub 2009 Aug 14.

13.

Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.

Huang H, Dawicki W, Zhang X, Town J, Gordon JR.

J Immunol. 2010 Nov 1;185(9):5003-10. doi: 10.4049/jimmunol.0903446. Epub 2010 Sep 24.

14.

Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.

Prochazkova J, Fric J, Pokorna K, Neuwirth A, Krulova M, Zajicova A, Holan V.

Immunology. 2009 Sep;128(1 Suppl):e670-8. doi: 10.1111/j.1365-2567.2009.03060.x. Epub 2009 Jan 24.

15.

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.

PMID:
19022917
16.

Expression of activation markers and cytokine mRNA by peripheral blood CD4 and CD8 T cells in atopic and nonatopic childhood asthma: effect of inhaled glucocorticoid therapy.

Gemou-Engesaeth V, Fagerhol MK, Toda M, Hamid Q, Halvorsen S, Groegaard JB, Corrigan CJ.

Pediatrics. 2002 Feb;109(2):E24.

PMID:
11826234
17.

Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus.

Liu Y, Zhu T, Cai G, Qin Y, Wang W, Tang G, Zhao D, Shen Q.

Lupus. 2011 May;20(6):620-7. doi: 10.1177/0961203310392431.

PMID:
21558138
18.

CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.

Rojo JM, Pini E, Ojeda G, Bello R, Dong C, Flavell RA, Dianzani U, Portolés P.

Int Immunol. 2008 Apr;20(4):577-89. doi: 10.1093/intimm/dxn016. Epub 2008 Feb 28.

PMID:
18310064
19.

Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis.

Han D, Wang C, Lou W, Gu Y, Wang Y, Zhang L.

Clin Immunol. 2010 Aug;136(2):292-301. doi: 10.1016/j.clim.2010.03.006. Epub 2010 Apr 18.

PMID:
20403730
20.

Supplemental Content

Support Center